American Journal of Kidney Diseases
Volume 50, Issue 1 , Pages 36-46 , July 2007

Recurrences and Infections During Continuous Immunosuppressive Therapy After Beginning Dialysis in ANCA-Associated Vasculitis

Received 31 October 2006 ,Accepted 23 April 2007.

References 

  1. Morgan MD, Harper L, Williams J, Savage C. Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol. 2006;17:1224–1234Epub April 19, 2006
  2. Watts R, Gonzalez-Gay M, Lane S, Garcia-Porrua C, Bentham G, Scott D. Geoepidemiology of systemic vasculitis: Comparison of the incidence in two regions of Europe. Ann Rheum Dis. 2001;60:170–172
  3. Westman KW, Bygren PG, Olsson H, Ranstam J, Wieslander J. Relapse rate, renal survival, and cancer morbidity in patients with Wegener’s granulomatosis or microscopic polyangiitis with renal involvement. J Am Soc Nephrol. 1998;9:842–852
  4. Booth AD, Almond MK, Burns A, et al. Outcome of ANCA-associated renal vasculitis: A 5-year retrospective study. Am J Kidney Dis. 2003;41:776–784
  5. Harper L, Savage CO. ANCA-associated renal vasculitis at the end of the twentieth century—A disease of older patients. Rheumatology (Oxford). 2005;44:495–501
  6. Allen A, Pusey C, Gaskin G. Outcome of renal replacement therapy in antineutrophil cytoplasmic antibody-associated systemic vasculitis. J Am Soc Nephrol. 1998;9:1258–1263
  7. Hogan SL, Falk RJ, Chin H, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med. 2005;143:621–631
  8. Jayne D. Current attitudes to the therapy of vasculitis. Kidney Blood Press Res. 2003;26:231–239
  9. Langford CA. How can relapses be detected and prevented in primary systemic small-vessel vasculitides?. Best Pract Res Clin Rheumatol. 2005;19:307–320
  10. Haubitz M, Koch KM, Brunkhorst R. Survival and vasculitis activity in patients with end-stage renal disease due to Wegener’s granulomatosis. Nephrol Dial Transplant. 1998;13:1713–1718
  11. Altieri P, Sau G, Cao R, et al. Immunosuppressive treatment in dialysis patients. Nephrol Dial Transplant. 2002;17(suppl 8):S2–S9
  12. Andrews PA, Warr KJ, Hicks JA, Cameron JS. Impaired outcome of continuous ambulatory peritoneal dialysis in immunosuppressed patients. Nephrol Dial Transplant. 1996;11:1104–1108
  13. Chonchol M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial. 2006;19:291–296
  14. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: The proposal of an International Consensus Conference. Arthritis Rheum. 1994;37:187–192
  15. Hunder HH, Arend WP, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis: Introduction. Arthritis Rheum. 1990;33:1065–1067
  16. Luqmani RA, Bacon PA, Moots RJ, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotising vasculitis. Q J Med. 1994;87:671–678
  17. Hellmich B, Flossmann O, Gross WL, et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: Focus on ANCA-associated vasculitis. Ann Rheum Dis. 2007;66:605–617
  18. Weidner S, Geuss S, Hafezi-Rachti S, Wonka A, Rupprecht HD. ANCA-associated vasculitis with renal involvement: An outcome analysis. Nephrol Dial Transplant. 2004;19:1403–1411Epub April 6, 2004
  19. Slot MC, Tervaert JW, Franssen CF, Stegeman CA. Renal survival and prognostic factors in patients with PR3-ANCA associated vasculitis with renal involvement. Kidney Int. 2003;63:670–677
  20. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349:36–44
  21. Oliver MJ, Rothwell DM, Fung K, Hux JE, Lok CE. Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol. 2004;15:1936–1942
  22. Descamps-Latscha B, Jungers P, Witko-Sarsat V. Immune system dysregulation in uremia: Role of oxidative stress. Blood Purif. 2002;20:481–484
  23. Birck R, Schmitt WH, Kaelsch IA, van der Woude FJ. Serial ANCA determinations for monitoring disease activity in patients with ANCA-associated vasculitis: Systematic review. Am J Kidney Dis. 2006;47:15–23

PII: S0272-6386(07)00740-8

doi: 10.1053/j.ajkd.2007.04.018

American Journal of Kidney Diseases
Volume 50, Issue 1 , Pages 36-46 , July 2007

Article Tools

* Image Usage & Resolution